Sylvester Comprehensive Cancer Center

News

Sylvester Researchers Discover New Pathway Linking Inflammation and Cancer

02.23.2018

A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, collaborating with outside investigators, has discovered a new pathway of inflammation-driven cancer development. Their findings, “Initiation of Inflammatory Tumorigenesis by CTLA4 Insufficiency Due to Type 2 Cytokines,” were published online on January 26 by the Journal of Experimental Medicine.

Barbara A. Vance, Ph.D., CRA.

Dr. Barbara A. Vance to Join Sylvester as Assistant VP and Associate Director for Administration

02.20.2018

Barbara A. Vance, Ph.D., CRA, will join Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine on March 17 as assistant vice president and associate director for administration. Vance will be a senior member of Sylvester’s leadership team, responsible for efficient operations and financial performance, including submission of the National Cancer Institute (NCI) Cancer Center Support Grant.

Team members of the Sylvester Phase 1 clinical trials program.

Sylvester Provides 100 Patients Potentially Life-Saving Treatments in its Phase 1 Trial Program

02.19.2018

Dr. Jaime Merchan is thrilled that Sylvester Comprehensive Cancer Center has reached the milestone number of 100 patients enrolled in a single year in its Phase 1 clinical trials program. The program, which tests new drugs and other novel treatment strategies for advanced solid tumors and hematological malignances, offers these patients something they couldn’t find elsewhere: hope.

Sylvester Comprehensive Cancer Center.

New Analysis: Patients Receiving Chemo for Cancer at ADCC Institutions Have Highest Survival Rates

02.19.2018

Patients treated with chemotherapy for some of the most common types of cancer at Dedicated Cancer Centers have higher survival rates compared to patients treated at other types of hospitals, according to new analysis conducted by Milliman for the Alliance of Dedicated Cancer Centers. Sylvester Comprehensive Cancer Center is one of only 11 members of the Alliance of Dedicated Cancer Centers.

Sylvester Comprehensive Cancer Center.

Sylvester Again Recognized as a Cancer Center of Excellence

02.16.2018

Sylvester Comprehensive Cancer Center has once again been recognized as a Cancer Center of Excellence by the State of Florida — one of just four cancer centers in the state, and the only one in South Florida, to have earned this honor. The designation recognizes providers that exceed service standards and excel in providing quality, comprehensive and patient-centered, coordinated care for cancer patients in Florida.

Adult bone marrow transplant procedure.

Florida Blue Renews Recognition of Sylvester's Adult Bone Marrow Transplant Program

02.13.2018

Florida Blue has renewed its Blue Distinction Center for Transplants designation for the adult bone marrow transplant program at Sylvester Comprehensive Cancer Center. The renewed designation is recognition that the program at Sylvester, part of UHealth – the University of Miami Health System, continues to meet the insurer’s national standards for high quality care and outcomes.

Erin N. Kobetz, Ph.D., M.P.H., Jimmy Patronis, and Stephen D. Nimer, M.D. (from left in center), with fire department representatives.

Florida CFO Jimmy Patronis Tours Sylvester, Praises Firefighters Cancer Initiative

02.09.2018

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine welcomed the State of Florida’s Chief Financial Officer, Jimmy Patronis, on February 5, giving him a tour of its cancer-fighting technologies. Patronis also met with representatives from more than a dozen of South Florida’s fire departments whose members are collaborating with Sylvester’s Firefighters Cancer Initiative.

From left, Alvaro J. Alencar, M.D., Edmundo Carvalho Mauad, M.D., Ph.D., Gilberto de Lima Lopes, M.D., M.B.A., Sergio Vicente Serrano, M.D., Ph.D., and Joseph D. Rosenblatt, M.D.

Sylvester and Brazil’s Barretos Cancer Hospital Sign Agreement for Collaborative Research

02.06.2018

Sylvester Comprehensive Cancer Center and Barretos Cancer Hospital — one of the most advanced public hospital cancer centers in Brazil — signed a memorandum of understanding on February 2 for wide-ranging collaborative research that may begin by the end of this year. Representatives from Barretos traveled to Miami to sign the agreement, meet with Sylvester researchers and clinicians, and tour Sylvester’s facilities.

From left, Alvaro J. Alencar, M.D., Edmundo Carvalho Mauad, M.D., Ph.D., Gilberto de Lima Lopes, M.D., M.B.A., Sergio Vicente Serrano, M.D., Ph.D., and Joseph D. Rosenblatt, M.D.

Sylvester and Brazil’s Barretos Cancer Hospital Sign Agreement for Collaborative Research

02.06.2018

Sylvester Comprehensive Cancer Center and Barretos Cancer Hospital — one of the most advanced public hospital cancer centers in Brazil — signed a memorandum of understanding on February 2 for wide-ranging collaborative research that may begin by the end of this year. Representatives from Barretos traveled to Miami to sign the agreement, meet with Sylvester researchers and clinicians, and tour Sylvester’s facilities.

Researchers discovered a direct link between G protein-coupled receptors and DNA demethylation.

Link between Environment and DNA May Have Implications for Human Health and Diseases

02.06.2018

Researchers from Sylvester Comprehensive Cancer Center, the John P. Hussman Institute for Human Genomics and The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine, in collaboration with colleagues from other institutions, have discovered a direct link between G protein-coupled receptors (GPCRs) and DNA demethylation — an important finding that could be implicated in human health and diseases.